Anyplex™Ⅱ RV16 Detection simultaneously detects and differentiates 16 of the most prevalent respiratory viruses that currently known in the clinical field. Based on Seegene’s proprietary DPO™ and TOCE™ technologies, this multiplex assay performs on real-time PCR instruments and provides infected information of 16 respiratory viruses in a single test with both high sensitivity and specificity.

Detection and differentiation of 16 respiratory viruses in a single reaction

Automated data interpretation and LIS interlocking with Seegene Viewer

Quick and proper treatment provided by accurate test results

Utilization of the UDG system to prevent carry-over contamination

Quantitative analysis by cyclic-CMTA

Convenient workflow using Seegene’s automated one platform

Whole process validation from extraction to PCR by whole process control

Assistant of appropriate treatment and management for co-infection

Multiplex real-time PCR with high sensitivity and specificity by utilization of DPO™ and TOCE™ technologies
The result represents co-infection that PIV4 is intermediate (++) in the FAM channel, RSV-A is high(+++) and RSA-B is high (+++) in the Cal Red 610 channel.
- Prevalence of human rinovirus infection in young children with acute wheezing
- Comparison of Anyplex II RV16 assay with conventional methods for detection of respiratory viruses
- Clinical and genetic features of human metapneumovirus infection in children
- Suboptimal effectiveness of the 2011-2012 seasonal influenza vaccine in adult korean populations
- Predictors of viral pneumonia in patients with community-acquired pneumonia
- Comparison of sputum and nasopharyngeal swabs for detection of respiratory viruses
[1] For use with Seegene NIMBUS & STARlet only